Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02DOP
|
|||
Former ID |
DNC004989
|
|||
Drug Name |
3-(1-Pyridin-2-yl-1H-pyrazol-3-yl)-benzonitrile
|
|||
Synonyms |
CHEMBL182771; 3-(1-Pyridin-2-yl-1H-pyrazol-3-yl)-benzonitrile; SCHEMBL3922673; LQROCYQCXGUXNA-UHFFFAOYSA-N; ZINC13582316; BDBM50151902
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H10N4
|
|||
Canonical SMILES |
C1=CC=NC(=C1)N2C=CC(=N2)C3=CC=CC(=C3)C#N
|
|||
InChI |
1S/C15H10N4/c16-11-12-4-3-5-13(10-12)14-7-9-19(18-14)15-6-1-2-8-17-15/h1-10H
|
|||
InChIKey |
LQROCYQCXGUXNA-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity. J Med Chem. 2004 Sep 9;47(19):4645-8. Letter |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.